Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125362781 | 12536278 | 1 | I | 20160417 | 20160627 | 20160707 | 20160707 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201606009051 | ELI LILLY AND CO | 70.09 | YR | M | Y | 0.00000 | 20160706 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125362781 | 12536278 | 1 | PS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 1000 MG, CYCLICAL | Y | U | 21462 | 1000 | MG | INJECTION | |||||
| 125362781 | 12536278 | 2 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 700 MG, CYCLICAL | Y | U | 21462 | 700 | MG | INJECTION | |||||
| 125362781 | 12536278 | 3 | C | CARBOPLATINE | CARBOPLATIN | 1 | UNK | 0 | |||||||||||
| 125362781 | 12536278 | 4 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG, UNKNOWN | 0 | 75 | MG | ||||||||
| 125362781 | 12536278 | 5 | C | SPECIAFOLDINE | FOLIC ACID | 1 | Oral | 0.4 MG, UNKNOWN | 0 | .4 | MG | ||||||||
| 125362781 | 12536278 | 6 | C | EMEND | APREPITANT | 1 | 0 | ||||||||||||
| 125362781 | 12536278 | 7 | C | ONDANSETRON | ONDANSETRON | 1 | 0 | ||||||||||||
| 125362781 | 12536278 | 8 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 0 | ||||||||||||
| 125362781 | 12536278 | 9 | C | SOLUPRED /00016201/ | PREDNISOLONE | 1 | 0 | ||||||||||||
| 125362781 | 12536278 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125362781 | 12536278 | 1 | Bronchial carcinoma |
| 125362781 | 12536278 | 3 | Lung carcinoma cell type unspecified stage IV |
| 125362781 | 12536278 | 4 | Cardiovascular event prophylaxis |
| 125362781 | 12536278 | 5 | Product used for unknown indication |
| 125362781 | 12536278 | 6 | Premedication |
| 125362781 | 12536278 | 7 | Premedication |
| 125362781 | 12536278 | 8 | Premedication |
| 125362781 | 12536278 | 9 | Premedication |
| 125362781 | 12536278 | 10 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125362781 | 12536278 | HO |
| 125362781 | 12536278 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125362781 | 12536278 | Haematotoxicity | |
| 125362781 | 12536278 | Haemoglobin decreased | |
| 125362781 | 12536278 | Hypocapnia | |
| 125362781 | 12536278 | Hypoxia | |
| 125362781 | 12536278 | Interstitial lung disease | |
| 125362781 | 12536278 | Off label use | |
| 125362781 | 12536278 | Thrombocytopenia | |
| 125362781 | 12536278 | Thrombophlebitis superficial | |
| 125362781 | 12536278 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125362781 | 12536278 | 1 | 20151201 | 0 | ||
| 125362781 | 12536278 | 2 | 20160405 | 0 | ||
| 125362781 | 12536278 | 3 | 20151201 | 20160202 | 0 | |
| 125362781 | 12536278 | 5 | 20151202 | 0 |